Pan-European private equity investor Bridgepoint Growth has taken a stake in Swedish medical dermatology group Diagnostiskt Centrum Hud (DCH). Financial terms have not been disclosed. Headquartered in Stockholm, DCH was founded in 2012 to address the untapped demand for high quality medical dermatology treatments. The market is underpinned by structural growth drivers, including an ageing…
©2021 All rights reserved LaingBuisson 
.){kind=link}